Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction.
Previous studies have documented that 0.1 approximately 1% of input recombinant adeno-associated virus (rAAV) vectors could be stabilized and lead to transgene expression. To characterize the steps involving massive AAV DNA loss, we designed an"AAV footprinting" strategy that can track newly formed AAV dsDNA genomes. This strategy is based on an ROSA26R mouse model or cell line that carries a lacZ gene flanked by two loxP sites. When it is transduced by a rAAV vector carrying the Cre recombinase, the lacZ gene can be activated and remain active even when rAAV genomes are later lost. By using this sensitive AAV footprinting technique, we confirmed the existence of transient AAV dsDNA that went undetected by conventional DNA methods. Although these dsDNA intermediates could be efficiently formed in almost every cell and were competent for mRNA transcription and protein synthesis in vivo, they got lost continuously. Only a small fraction was eventually stabilized for sustained gene expression. Although both rAAV2 and rAAV8 can potentially have similar levels of dsDNA formation, AAV8 dsDNA was formed much faster than that of AAV2, which explains why rAAV8 is more efficient than rAAV2 in transducing the liver. Collectively, our studies suggested that rather than receptor binding, viral entry, and ssDNA to dsDNA conversion, the instability of newly formed AAV dsDNA was the primary contributing factor for the low rAAV transduction efficacy. The uncoating step significantly influenced the stability of AAV transient dsDNA. The identification of transient AAV dsDNA provided a new pathway for improving rAAV transduction.
Wang
Jinhui
J
Department of Pediatrics, University of Pennsylvania Health Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Xie
Jing
J
Lu
Hui
H
Chen
Lingxia
L
Hauck
Bernd
B
Samulski
Richard Jude
RJ
Xiao
Weidong
W
D000469:Alkaline Phosphatase / Q000235:genetics; D004279:DNA, Viral / Q000235:genetics*; D000229:Dependovirus / Q000235:genetics*; D015316:Genetic Therapy; D005822:Genetic Vectors; D016679:Genome, Viral; D042822:Genomic Instability; D019426:Integrases / Q000235:genetics; D008099:Liver / Q000378:metabolism; D010957:Plasmids; D011995:Recombination, Genetic; D014161:Transduction, Genetic
D004279:DNA, Viral; C045073:Cre recombinase; D019426:Integrases; D000469:Alkaline Phosphatase